Viridian Therapeutics (VRDN)
NASDAQ:VRDN
Want to see VRDN full AI Analyst Report?
Viridian Therapeutics (VRDN) Ownership Overview
4.99% Insiders
27.27% Mutual Funds
44.06% Other Institutional Investors
16.23% ETFs
7.43% Public Companies and
Individual Investors
The ownership structure of Viridian Therapeutics (VRDN) stock is a mix of institutional, retail, and individual investors. Approximately 87.57% of the company’s stock is owned by Institutional Investors, 4.99% is owned by Insiders, and 7.43% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 13, 2026 | xxxxxxxxxxxxx | $19999990 | |
Oct 27, 2025 | xxxxxxxxxxxxx | $9999990 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $22901415 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $13710171 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $34587850 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $400002 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,090,928 | Insider | 4.94% | 87,767,599 | |
| 4,910,967 | Institution | 4.76% | 84,665,071 | |
| 3,914,458 | Institution | 3.80% | 67,485,256 | |
| 3,820,704 | Institution | 3.71% | 65,868,937 | |
| 3,712,010 | Institution | 3.60% | 63,995,052 | |
| 3,380,950 | Institution | 3.28% | 58,287,578 | |
| 3,282,464 | Institution | 3.18% | 56,589,679 | |
| 3,192,455 | Institution | 3.10% | 55,037,924 | |
| 3,090,122 | Institution | 3.00% | 53,273,703 | |
| 2,645,928 | Institution | 2.57% | 45,615,799 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,820,704 | Institution | 3.71% | 65,868,937 | |
| 3,712,010 | Institution | 3.60% | 63,995,052 | |
| 3,282,464 | Institution | 3.18% | 56,589,679 | |
| 2,645,928 | Institution | 2.57% | 45,615,799 | |
| 1,270,795 | Institution | 1.23% | 21,908,506 | |
| 1,058,110 | Institution | 1.03% | 18,241,816 | |
| 1,014,786 | Institution | 0.98% | 17,494,911 | |
| 968,594 | Institution | 0.94% | 16,698,561 | |
| 923,711 | Institution | 0.90% | 15,924,778 | |
| 849,680 | Institution | 0.82% | 14,648,483 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,118,860 | Institution | 3.03% | 61,004,902 | |
| 2,919,512 | Institution | 2.83% | 50,215,606 | |
| 1,905,355 | Institution | 1.85% | 32,124,285 | |
| 948,317 | Institution | 0.92% | 18,549,081 | |
| 827,387 | Institution | 0.80% | 14,231,056 | |
| 827,387 | Institution | 0.80% | 14,231,056 | |
| 827,387 | Institution | 0.80% | 14,231,056 | |
| 530,835 | Institution | 0.52% | 8,949,878 | |
| 416,753 | Institution | 0.40% | 7,168,152 | |
| 400,541 | Institution | 0.39% | 7,834,582 |
FAQ
Who Owns Viridian Therapeutics (VRDN)?
According to the latest TipRanks data, approximately 44.06% of the company's stock is held by institutional investors, 4.99% is held by insiders, and 7.43% is held by retail investors.
What percentage of Viridian Therapeutics (VRDN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 44.06% of Viridian Therapeutics (VRDN) stock is held by institutional investors.
What percentage of Viridian Therapeutics (VRDN) stock is held by retail investors?
According to the latest TipRanks data, approximately 7.43% of Viridian Therapeutics (VRDN) stock is held by retail investors.
Who owns the most shares of Viridian Therapeutics (VRDN)?
Fairmount Funds Management LLC owns the most shares of Viridian Therapeutics (VRDN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.